M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.06 USD -1.6% Market Closed
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MoonLake Immunotherapeutics
Research & Development Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Research & Development
-$31.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Research & Development
-$127.1m
CAGR 3-Years
3%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Research & Development
-CHf59.4m
CAGR 3-Years
0%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Research & Development
-$333.6m
CAGR 3-Years
5%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Research & Development
-CHf63.3m
CAGR 3-Years
0%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Research & Development
-CHf250.9k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Research & Development?
Research & Development
-31.8m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Research & Development amounts to -31.8m USD.

What is MoonLake Immunotherapeutics's Research & Development growth rate?
Research & Development CAGR 1Y
24%

Over the last year, the Research & Development growth was 24%.

Back to Top